OTC · Drug Manufacturers - Specialty & Generic

Resonate Blends, Inc. (KOAN) Stock

$0.00 OTC: KOAN Healthcare

APOLLO BioWellness Inc. focuses its efforts on researching, formulating, and bringing to market products designed for human health within the regenerative medicine sector.

Valuation

MetricValue
Price$0.00
Market Cap$97625
P/E Ratio-0.05
P/B Ratio-0.03
P/S Ratio0.08
EPS (TTM)$-0.01
52-Week High$0.02
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE40.00%
ROA-28.22%
ROCE16.51%
Gross Margin65.52%
Operating Margin-76.66%
Net Margin51.23%
Debt/Equity-1.00
Current Ratio0.22

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$2.0M$2.0M
Operating Profit$-3.0M$-1.0M$0$-2.0M$-1.0M
Net Profit$-5.0M$3.0M$-1.0M$-2.0M$-2.0M
EPS$-0.16$0.04$-0.02$-0.02$-0.01
Op Margin-9364.8%-2806.8%-2424.2%-89.5%-57.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$0$0$1.0M$2.0M$2.0M
Total Liabilities$4.0M$2.0M$3.0M$5.0M$7.0M
Cash$0$0$0$0$0
Borrowings$2.0M$1.0M$2.0M$4.0M$5.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-3.0M$-1.0M$0$-1.0M$-2.0M
Investing Cash Flow$0$0$-1.0M$0$0
Financing Cash Flow$3.0M$1.0M$0$0$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$-3.0M$-1.0M$0$-1.0M$-2.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-6.27
FCF Yield-1623.27%
Quick Ratio0.21
Interest Coverage-0.68
Return 1Y-89.13%
Return 3Y-99.34%
Return 5Y—

Ownership

Insiders Held1.50%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANTCFAion Therapeutic Inc. $0.00 — — $2.07M 0.00%
BHNGFBhang Inc. $0.00 — -0.01 $19965 0.00%
EVIOEVIO, Inc. $0.00 — 1.67 $959685 0.00%
HEMPHemp, Inc $0.00 — -0.25 $882950 0.00%
JWCAFJames E. Wagner Cultivation Corporation $0.00 — 0.00 $10942 0.00%

About Resonate Blends, Inc.

APOLLO BioWellness Inc. focuses its efforts on researching, formulating, and bringing to market products designed for human health within the regenerative medicine sector. A significant part of its operations involves the commercialization of licensed, naturally derived compounds currently awaiting patent approval, which are specifically engineered to boost an individual's innate capacity to mobilize adult stem cells from their own bone marrow. Additionally, the firm possesses the marketing rights for an all-natural, two-pronged dietary supplement crafted to help regulate hunger by engaging the body's intrinsic signaling pathways between the brain and the digestive system. Beyond its current offerings, the company is also deeply involved in research and development initiatives. These efforts are dedicated to exploring new frontiers, such as Secretogues aimed at enhancing a person's endogenous growth hormone synthesis, along with other natural bioactive formulations intended to optimize human physiological performance. This is achieved by harnessing the body's own biological mechanisms, entirely without the use of pharmaceutical drugs. The company maintains its corporate headquarters in North Bergen, New Jersey.

Resonate Blends, Inc. (KOAN) stock trades at $0.00 with a market capitalization of $97625. The stock is valued at a price-to-earnings (P/E) ratio of -0.05, price-to-book of -0.03, price-to-sales of 0.08. Over the past 52 weeks the stock has ranged between $0.00 and $0.02, and currently trades 100.0% below its 52-week high.

On profitability, Resonate Blends, Inc. generates a return on equity (ROE) of 40.00% — well above the market average, a sign of a high-quality business, return on capital employed of 16.51%, an operating margin of -76.66%, a net profit margin of 51.23%.

Official website: www.apollobiowellness.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides